microRNA 4256 (MIR4256)

microRNA 4256 (MIR4256, also referred to as hsa-mir-4256 or hsa-miR-4256) is a non-coding RNA molecule belonging to the microRNA (miRNA) class[7]. MicroRNAs are approximately 22 nucleotides in length and regulate gene expression at the post-transcriptional level by binding to complementary sequences in the 3′ untranslated regions (UTRs) of target messenger RNA (mRNA) molecules, leading to mRNA degradation or inhibition of translation[1][4][6]. This general mode of action underlies their critical roles in cellular processes such as development, differentiation, proliferation, and apoptosis[6]. \nThere is no evidence in curated databases or the scientific literature indicating that MIR4256 is recognized as a direct therapeutic target (such as a receptor, enzyme, transporter, or other protein drug target)[7]. Rather, MIR4256 and other microRNAs may be considered as potential biomarkers or as targets for experimental modulation of gene expression, but such applications are not established for this specific microRNA. \nNo validated disease association, specific drug interactions, mechanism-of-action data, or safety concerns have been documented for MIR4256 as of September 2025. \nNote: While microRNAs as a class play a major role in diseases—most notably in cancer biology and as biomarkers in various conditions—there is insufficient information for MIR4256 to support distinct clinical or therapeutic categorization at this time[7]. \n\n**Special note regarding correctness:** \n- Despite having valid nomenclature and being present in miRNA reference databases, microRNA 4256 (MIR4256) is not a standard drug target, therapeutic target, or receptor—nor is it listed as functionally characterized beyond generic miRNA activities. If your intent is to identify conventional therapeutic targets (e.g., receptors, enzymes), MIR4256 does not meet that definition and would be considered \“incorrect\” or \“out of scope\” for those purposes.

Other names

hsa-mir-4256hsa-miR-4256MIR4256